IKNA logo

Ikena Oncology (IKNA) Company Overview

Profile

Full Name:

Ikena Oncology, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 26, 2021

Indexes:

Not included

Description:

Ikena Oncology (IKNA) is a biotechnology company focused on developing targeted therapies for cancer treatment. They aim to create innovative medicines that improve patient outcomes by addressing specific genetic and molecular drivers of cancer. Their research combines advanced science with a commitment to patient care.

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 11, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
May 29, 24 Wedbush
Neutral
May 29, 24 HC Wainwright & Co.
Buy
May 14, 24 Wedbush
Outperform
Mar 19, 24 HC Wainwright & Co.
Buy
Mar 12, 24 HC Wainwright & Co.
Buy
Jan 19, 24 Wedbush
Outperform
Jan 19, 24 HC Wainwright & Co.
Buy
Nov 9, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Ikena Oncology?
  • Does Ikena Oncology pay dividends?
  • What sector is Ikena Oncology in?
  • What industry is Ikena Oncology in?
  • What country is Ikena Oncology based in?
  • When did Ikena Oncology go public?
  • Is Ikena Oncology in the S&P 500?
  • Is Ikena Oncology in the NASDAQ 100?
  • Is Ikena Oncology in the Dow Jones?
  • When was Ikena Oncology's last earnings report?
  • When does Ikena Oncology report earnings?
  • Should I buy Ikena Oncology stock now?

What is the ticker symbol for Ikena Oncology?

The ticker symbol for Ikena Oncology is NASDAQ:IKNA

Does Ikena Oncology pay dividends?

No, Ikena Oncology does not pay dividends

What sector is Ikena Oncology in?

Ikena Oncology is in the Healthcare sector

What industry is Ikena Oncology in?

Ikena Oncology is in the Biotechnology industry

What country is Ikena Oncology based in?

Ikena Oncology is headquartered in United States

When did Ikena Oncology go public?

Ikena Oncology's initial public offering (IPO) was on March 26, 2021

Is Ikena Oncology in the S&P 500?

No, Ikena Oncology is not included in the S&P 500 index

Is Ikena Oncology in the NASDAQ 100?

No, Ikena Oncology is not included in the NASDAQ 100 index

Is Ikena Oncology in the Dow Jones?

No, Ikena Oncology is not included in the Dow Jones index

When was Ikena Oncology's last earnings report?

Ikena Oncology's most recent earnings report was on Nov 7, 2024

When does Ikena Oncology report earnings?

The next expected earnings date for Ikena Oncology is Mar 12, 2025

Should I buy Ikena Oncology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions